Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeping Zuo

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Inflammation Research|October 4, 2023
Xianglian Zhixie Tablet Antagonizes Dextran Sulfate Sodium-Induced Ulcerative Colitis by Attenuating Systemic Inflammation and Modulating Gut MicrobiotaYilin Li, Tingting Wang, Beibei Ma, et al.
Medical Oncology (Northwood, London, England)|September 7, 2021
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagyHuan Liu, Jing Wei, Na Sang, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonistsZeping Zuo, Miaomiao Chen, Xiaoni Shao, et al.
Cancer & Metabolism|May 11, 2021
DHODH and cancer: promising prospects to be exploredYue Zhou, Lei Tao, Xia Zhou, et al.
Cancer Letters|April 13, 2019
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathwayYan Li, Lei Tao, Zeping Zuo, et al.
Journal of Medicinal Chemistry|June 5, 2020
Bifunctional Naphtho[2,3-<i>d</i>][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species ProductionZeping Zuo, Xiaocong Liu, Xinying Qian, et al.
Journal of Medicinal Chemistry|November 28, 2023
A Novel Bifunctional μOR Agonist and σ<sub>1</sub>R Antagonist with Potent Analgesic Responses and Reduced Adverse EffectsZhuang Miao, Yuhan Zhong, Yu Gan, et al.
Medcomm|May 30, 2023
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45BNa Sang, Xi Zhong, Kun Gou, et al.
Nature Communications|November 17, 2023
Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51Lei Tao, Yue Zhou, Xiangyu Pan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Inflammation Research|October 4, 2023
Xianglian Zhixie Tablet Antagonizes Dextran Sulfate Sodium-Induced Ulcerative Colitis by Attenuating Systemic Inflammation and Modulating Gut MicrobiotaYilin Li, Tingting Wang, Beibei Ma, et al.
Medical Oncology (Northwood, London, England)|September 7, 2021
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagyHuan Liu, Jing Wei, Na Sang, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonistsZeping Zuo, Miaomiao Chen, Xiaoni Shao, et al.
Cancer & Metabolism|May 11, 2021
DHODH and cancer: promising prospects to be exploredYue Zhou, Lei Tao, Xia Zhou, et al.
Cancer Letters|April 13, 2019
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathwayYan Li, Lei Tao, Zeping Zuo, et al.
Journal of Medicinal Chemistry|June 5, 2020
Bifunctional Naphtho[2,3-<i>d</i>][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species ProductionZeping Zuo, Xiaocong Liu, Xinying Qian, et al.
Journal of Medicinal Chemistry|November 28, 2023
A Novel Bifunctional μOR Agonist and σ<sub>1</sub>R Antagonist with Potent Analgesic Responses and Reduced Adverse EffectsZhuang Miao, Yuhan Zhong, Yu Gan, et al.
Medcomm|May 30, 2023
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45BNa Sang, Xi Zhong, Kun Gou, et al.
Nature Communications|November 17, 2023
Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51Lei Tao, Yue Zhou, Xiangyu Pan, et al.
Pageof 3